PREVYMIS 480 mg/1
LETERMOVIR · TABLET, FILM COATED · Merck Sharp & Dohme LLC
Prevymis is a prescription tablet used to prevent cytomegalovirus (CMV) infection in certain patients who have received a stem cell or bone marrow transplant. It works by inhibiting an enzyme that the virus needs to replicate its DNA.
Key Facts
- Brand Name
- PREVYMIS
- Generic Name
- LETERMOVIR
- NDC Code (Product)
0006-3076- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 480 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209939
- Drug Class
- Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
- Marketing Start
- 11/08/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is PREVYMIS used for?
Prevymis is a prescription tablet used to prevent cytomegalovirus (CMV) infection in certain patients who have received a stem cell or bone marrow transplant. It works by inhibiting an enzyme that the virus needs to replicate its DNA.
Is PREVYMIS a controlled substance?
PREVYMIS is not classified as a controlled substance by the DEA.
What is the generic name for PREVYMIS?
The generic name for PREVYMIS is LETERMOVIR. There are no other listed brand versions of LETERMOVIR.
What is the NDC code for PREVYMIS 480 mg/1?
The NDC (National Drug Code) for PREVYMIS 480 mg/1 is 0006-3076, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)